Text of Senate Amendment 1216

Text of Senate Amendment 1216

Congressional Record, Volume 171 Issue 34 (Thursday, February 20, 2025) [Congressional Record Volume 171, Number 34 (Thursday, February 20, 2025)] [Senate] [Page S1301] From the Congressional Record Online through the Government Publishing Office [ www.gpo.gov ] SA 1216. Ms. ROSEN submitted an amendment intended to be proposed by her to the concurrent resolution S. Con. Res. 7, setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; which was ordered to lie on the table; as follows: At the appropriate place in title IV, add the following: SEC. 4___. POINT OF ORDER AGAINST INCREASING THE COST OF PRESCRIPTION DRUGS. (a) Point of Order.--It shall not be in order in the Senate to consider any bill, joint resolution, motion, amendment, amendment between the Houses, or conference report that would increase the cost of prescription drugs, including by repealing the $35 insulin cap for Medicare beneficiaries, increasing out-of-pocket costs for Medicare beneficiaries, or increasing drug costs for Medicaid patients, patients with private health insurance, patients covered by TRICARE, or uninsured patients. (b) Waiver and Appeal.--Subsection (a) may be waived or suspended in the Senate only by an affirmative vote of three- fifths of the Members, duly chosen and sworn. An affirmative vote of three-fifths of the Members of the Senate, duly chosen and sworn, shall be required to sustain an appeal of the ruling of the Chair on a point of order raised under subsection (a). ______